Neurostimulation device for ameliorating salivary dysfunction: A novel neuromodulatory perspective

Xerostomia, or dry mouth, is a condition characterised by a decrease in salivary flow rate, affecting the quality of life of many individuals. Factors contributing to xerostomia include radiation therapy, pathologies, medications, and age-related loss of salivary gland function. Traditional manageme...

Full description

Saved in:
Bibliographic Details
Main Authors: Rajkumar Krishnan, Nagarathinam Anbu Elangovan, Ramya Ramadoss
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Oral Oncology Reports
Online Access:http://www.sciencedirect.com/science/article/pii/S277290602400219X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553786886160384
author Rajkumar Krishnan
Nagarathinam Anbu Elangovan
Ramya Ramadoss
author_facet Rajkumar Krishnan
Nagarathinam Anbu Elangovan
Ramya Ramadoss
author_sort Rajkumar Krishnan
collection DOAJ
description Xerostomia, or dry mouth, is a condition characterised by a decrease in salivary flow rate, affecting the quality of life of many individuals. Factors contributing to xerostomia include radiation therapy, pathologies, medications, and age-related loss of salivary gland function. Traditional management approaches have focused on pharmacological interventions and symptom relief; however, innovative therapies are needed to address the underlying causes of salivary gland dysfunction. Neurostimulation is a rapidly evolving field that holds promise for managing xerostomia by targeting the neural pathways involved in salivary secretion. Studies have shown the efficacy of transcutaneous electrical stimulation in enhancing salivary secretion by selectively activating the nerves innervating the salivary glands. Neurostimulation offers a targeted and personalised approach to treatment, allowing for precise modulation of salivary gland function based on individual patient needs. Neurostimulation devices for xerostomia include the biosonics-SAL salivator system, AdvanTeq 2000, GenNarino, Mediheightec 8000, and the custom extraoral wearable device developed by Rajkumar et al. Neurostimulation is a promising therapeutic approach for managing xerostomia; however, further research is needed to validate the underlying mechanisms and optimise neurostimulation techniques for optimal salivary secretion.
format Article
id doaj-art-f6e5435f00824d9494bb20c03c73c0b9
institution Kabale University
issn 2772-9060
language English
publishDate 2024-06-01
publisher Elsevier
record_format Article
series Oral Oncology Reports
spelling doaj-art-f6e5435f00824d9494bb20c03c73c0b92025-01-09T06:15:59ZengElsevierOral Oncology Reports2772-90602024-06-0110100373Neurostimulation device for ameliorating salivary dysfunction: A novel neuromodulatory perspectiveRajkumar Krishnan0Nagarathinam Anbu Elangovan1Ramya Ramadoss2Department of Oral Pathology, SRM Dental College, Ramapuram, Chennai, IndiaDepartment of Oral Pathology, SRM Dental College, Ramapuram, Chennai, India; Corresponding author.Department of Oral Biology, Saveetha Dental College, Chennai, IndiaXerostomia, or dry mouth, is a condition characterised by a decrease in salivary flow rate, affecting the quality of life of many individuals. Factors contributing to xerostomia include radiation therapy, pathologies, medications, and age-related loss of salivary gland function. Traditional management approaches have focused on pharmacological interventions and symptom relief; however, innovative therapies are needed to address the underlying causes of salivary gland dysfunction. Neurostimulation is a rapidly evolving field that holds promise for managing xerostomia by targeting the neural pathways involved in salivary secretion. Studies have shown the efficacy of transcutaneous electrical stimulation in enhancing salivary secretion by selectively activating the nerves innervating the salivary glands. Neurostimulation offers a targeted and personalised approach to treatment, allowing for precise modulation of salivary gland function based on individual patient needs. Neurostimulation devices for xerostomia include the biosonics-SAL salivator system, AdvanTeq 2000, GenNarino, Mediheightec 8000, and the custom extraoral wearable device developed by Rajkumar et al. Neurostimulation is a promising therapeutic approach for managing xerostomia; however, further research is needed to validate the underlying mechanisms and optimise neurostimulation techniques for optimal salivary secretion.http://www.sciencedirect.com/science/article/pii/S277290602400219X
spellingShingle Rajkumar Krishnan
Nagarathinam Anbu Elangovan
Ramya Ramadoss
Neurostimulation device for ameliorating salivary dysfunction: A novel neuromodulatory perspective
Oral Oncology Reports
title Neurostimulation device for ameliorating salivary dysfunction: A novel neuromodulatory perspective
title_full Neurostimulation device for ameliorating salivary dysfunction: A novel neuromodulatory perspective
title_fullStr Neurostimulation device for ameliorating salivary dysfunction: A novel neuromodulatory perspective
title_full_unstemmed Neurostimulation device for ameliorating salivary dysfunction: A novel neuromodulatory perspective
title_short Neurostimulation device for ameliorating salivary dysfunction: A novel neuromodulatory perspective
title_sort neurostimulation device for ameliorating salivary dysfunction a novel neuromodulatory perspective
url http://www.sciencedirect.com/science/article/pii/S277290602400219X
work_keys_str_mv AT rajkumarkrishnan neurostimulationdeviceforamelioratingsalivarydysfunctionanovelneuromodulatoryperspective
AT nagarathinamanbuelangovan neurostimulationdeviceforamelioratingsalivarydysfunctionanovelneuromodulatoryperspective
AT ramyaramadoss neurostimulationdeviceforamelioratingsalivarydysfunctionanovelneuromodulatoryperspective